Drug Class IGF-1R antagonist (monoclonal antibody).

Lumvoa (Veligrotug) FDA Approval: Thyroid Eye Disease

Lumvoa (Veligrotug) FDA Approval

{ “@context”: “https://schema.org”, “@type”: “Drug”, “name”: “Lumvoa”, “alternateName”: [“veligrotug-vvze”, “veligrotug”, “VRDN-001”], “nonProprietaryName”: “veligrotug-vvze”, “manufacturer”: { “@type”: “Organization”, “name”: “Viridian Therapeutics, Inc.” }, “administrationRoute”: “Intravenous infusion”, “drugClass”: “IGF-1R antagonist (monoclonal antibody)”, “prescriptionStatus”: “PrescriptionOnly”, “clinicalPharmacology”: “Full antagonist of the insulin-like growth factor-1…